𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized controlled study of (2″ R)-4'-O-tetrahydropyranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast cancer

✍ Scribed by Tominaga, T.; Abe, O.; Enomoto, K.; Abe, R.; Iino, Y.; Koyama, H.; Fujimoto, M.; Nomura, Y.

Book ID
122546861
Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
870 KB
Volume
43
Category
Article
ISSN
0753-3322

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized multicenter trial of cyclop
A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer
✍ John M. Bennett; Patrick Byrne; Ajit Desai; Charles White; Ronald DeConti; Charl 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 388 KB

As of August 1984, 115 women with advanced breast cancer have been randomized to receive a combination of either cyclophosphamide, Novantrone (mitoxantrone) and 5-fluorouracil (CNF) or cyclophosphamide, Adriamycin (doxorubicin) and 5-fluorouracil (CAF). Seventy-one percent of all patients were post-

Treatment of advanced ovarian cancer: A
Treatment of advanced ovarian cancer: A randomised trial comparing adriamycin or 4′epi-adriamycin in combination with cisplatin and cyclophosphamide
✍ Bezwoda, W. R. 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Fifty-one patients with ovarian cancer were tients with < 2 cm residual disease had sigentered in a randomised trial comparing treat-nificantly higher rate of complete remission rnent with cisplatin + adriamycin + cyclo-than those with > 2 crn residual disease. Carphosphamide (PAC) to cisplatin + 4'